These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16804327)

  • 1. Allergenic extracts for specific immunotherapy: to mix or not to mix?
    Mari A; Scala E
    Int Arch Allergy Immunol; 2006; 141(1):57-60. PubMed ID: 16804327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens.
    Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H
    Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New approaches for allergen-specific immunotherapy].
    Cantillo JF; Puerta L
    Biomedica; 2010; 30(3):440-53. PubMed ID: 21713346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE; Bush RK; Peden D; Lockey RF
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Component-resolved diagnosis-assisted prescription of allergen-specific immunotherapy: a practical guide.
    Asero R
    Eur Ann Allergy Clin Immunol; 2012 Oct; 44(5):183-7. PubMed ID: 23156065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific immunotherapy with allergen mixes: what is the evidence?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Date palm pollen allergoid: characterization of its chemical-physical and immunological properties.
    Mistrello G; Harfi H; Roncarolo D; Kwaasi A; Zanoni D; Falagiani P; Panzani R
    Int Arch Allergy Immunol; 2008; 145(3):224-30. PubMed ID: 17914274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts.
    Portnoy J; Bagstad K; Kanarek H; Pacheco F; Hall B; Barnes C
    Ann Allergy; 1994 Nov; 73(5):409-18. PubMed ID: 7978533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.
    Grier TJ
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):201-5. PubMed ID: 22374205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
    Paranos S; Petrović S; Vojović I
    Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms.
    Bousquet J
    Allergy; 2005 Jan; 60(1):1-3. PubMed ID: 15575923
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.